alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
```

[Congressional Bills 111th Congress]
[From the U.S. Government Publishing Office]
[H.R. 3668 Introduced in House (IH)]

111th CONGRESS
  1st Session
                                H. R. 3668

   To amend the Public Health Service Act to reauthorize the special 
   diabetes programs for Type I diabetes and Indians under that Act.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                           September 29, 2009

 Ms. DeGette (for herself, Mr. Castle, Mr. Kirk, Mr. Space, Mr. Cole, 
 Mr. Kildee, and Mr. Becerra) introduced the following bill; which was 
            referred to the Committee on Energy and Commerce

_______________________________________________________________________

                                 A BILL

 
   To amend the Public Health Service Act to reauthorize the special 
   diabetes programs for Type I diabetes and Indians under that Act.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. REAUTHORIZATION OF SPECIAL DIABETES PROGRAMS FOR TYPE I 
              DIABETES AND INDIANS.

    (a) Special Diabetes Programs for Type I Diabetes.--Section 
330B(b)(2) of the Public Health Service Act (42 U.S.C. 254c-2(b)(2)) is 
amended--
            (1) in subparagraph (B), by striking ``and'' at the end;
            (2) in subparagraph (C), by striking the period at the end 
        and inserting ``; and''; and
            (3) by adding at the end the following:
                    ``(D) $200,000,000 for each of the fiscal years 
                2012 through 2016.''.
    (b) Special Diabetes Programs for Indians.--Section 330C(c)(2) of 
the Public Health Service Act (42 U.S.C. 254c-3(c)(2)) is amended--
            (1) in subparagraph (B), by striking ``and'' at the end;
            (2) in subparagraph (C), by striking the period at the end 
        and inserting ``; and''; and
            (3) by adding at the end the following:
                    ``(D) $200,000,000 for each of the fiscal years 
                2012 through 2016.''.
                                 <all>
```
U.S. Department of Transportation, 

Dockets 

Attn: Dockets OST 98-3304 

400 Seventh St. S.W. 

PL401 

Washington DC, 20590 

USA 

29th January 2013 

Dear Sir, 

··, 

-' 

Li 

".ii.) 

Kenyon House 

1 The Western Centre 

Western Road 

Bracknell 

RG12 1RW 

Telephone (24 hrs): 

+44 (0) 1344 316 650 

Fax: 

+44 (0) 1344 316 699 

Email: 

kenyon@kenyoninternational.com 

Website: 

www.kenyonintemational.com 

This letter is to inform you that from Friday 1st February 2013, Kenyon will no 

longer provide third party recovery support to Insel Air in the event of mass 

fatality incident under the U.S. Aviation Disaster Family Assistance Act of 1996. 

If you have any questions relating to this letter, please contact me at the above 

address. 

Yours faithfully 

Jeremy Allen 

Vice President 

Cc. Albert Kluijver- Insel Air 

Kenyon UK a branch of Kenyon International Emergency Services Inc., 

15180 Grand Point Drive, Houston. Texas 77090. Company Reg. No. FC24150. VAT Reg. No. 793 0410 38
Exhibit 21.1 - LIST OF SUBSIDIARIES



1.  Exabyte FSC Ltd.

2.  Nihon Exabyte Corporation

3.  Exabyte (Scotland) Ltd.

4.  Exabyte (Europe) B.V.

5.  Exabyte Magnetics GmbH

6.  Exabyte (Singapore) Pte. Ltd.

7.  Exabyte (Canada) Corporation
I 

111TH CONGRESS 

1ST SESSION H. R. 3920 

To amend the Internal Revenue Code of 1986 to provide for a waiver of 

minimum required distribution rules applicable to pension plans for 2010. 

IN THE HOUSE OF REPRESENTATIVES 

OCTOBER 23, 2009 

Mr. BURGESS introduced the following bill; which was referred to the 

Committee on Ways and Means 

A BILL 

To amend the Internal Revenue Code of 1986 to provide 

for a waiver of minimum required distribution rules applicable to pension plans for 2010. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. WAIVER OF PENSION PLAN MINIMUM RE4 QUIRED DISTRIBUTION RULES FOR 2010. 

5 (a) IN GENERAL.—Clause (i) of section 401(a)(9)(H) 

6 of the Internal Revenue Code of 1986 (relating to general 

7 rule for temporary waiver of minimum required distribu8 tion) is amended by striking ‘‘calendar year 2009’’ and 

9 inserting ‘‘calendar years 2009 and 2010’’. 

10 (b) CONFORMING AMENDMENTS.— 


hsrobinson on DSK69SOYB1PROD with BILLS
2 

•HR 3920 IH

1 (1) Clause (ii) of section 401(a)(9)(H) of such 

2 Code is amended— 

3 (A) in subclause (I) by striking ‘‘2009’’ 

4 and inserting ‘‘2010’’, and 

5 (B) in subclause (II) by striking ‘‘calendar 

6 year 2009’’ and inserting ‘‘calendar years 2009 

7 and 2010’’. 

8 (2) Paragraph (4) of section 402(c) of such 

9 Code is amended— 

10 (A) by striking ‘‘2009’’ the first place it 

11 appears and inserting ‘‘2009 or 2010’’, and 

12 (B) by striking ‘‘2009,’’ the second place it 

13 appears and inserting ‘‘2009 or 2010, as the 

14 case may be,’’. 

15 (c) EFFECTIVE DATE.— 

16 (1) IN GENERAL.—The amendments made by 

17 this section shall apply to calendar years beginning 

18 after December 31, 2009. 

19 (2) PROVISIONS RELATING TO PLAN OR CON20 TRACT AMENDMENTS.— 

21 (A) IN GENERAL.—If this paragraph ap22 plies to any pension plan or contract amend23 ment, such pension plan or contract shall not 

24 fail to be treated as being operated in accord25 ance with the terms of the plan during the peVerDate Nov 24 2008 23:02 Oct 23, 2009 Jkt 089200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\H3920.IH H3920

hsrobinson on DSK69SOYB1PROD with BILLS
3 

•HR 3920 IH

1 riod described in subparagraph (B)(ii) solely be2 cause the plan operates in accordance with this 

3 section. 

4 (B) AMENDMENTS TO WHICH PARAGRAPH

5 APPLIES.— 

6 (i) IN GENERAL.—This paragraph 

7 shall apply to any amendment to any pen8 sion plan or annuity contract which— 

9 (I) is made pursuant to the 

10 amendments made by this section, 

11 and 

12 (II) is made on or before the last 

13 day of the first plan year beginning 

14 on or after January 1, 2012. 

15 In the case of a governmental plan, sub16 clause (II) shall be applied by substituting 

17 ‘‘2013’’ for ‘‘2012’’. 

18 (ii) CONDITIONS.—This paragraph 

19 shall not apply to any amendment unless 

20 during the period beginning on the effec21 tive date of the amendment and ending on 

22 December 31, 2010, the plan or contract is 

23 operated as if such plan or contract 

24 amendment were in effect. 

Æ 


hsrobinson on DSK69SOYB1PROD with BILLS
MARCH, 1812.

c#se isífc

#### W. H. *Gibbes,*Master in Equity, *vs.*Othniel Giles and Wife.

[in the Court of Appeals,

25th March, 1812.]

*itT is*ordered that the decretal order made by the cjjA trait court so far as respects the payment of the *money?*fee affirmed. But it being represented to the court that there is a marriage settlement in this case which comprehends the property in question, it is further ordered that* the money be paid over to the trustee in the said marriage sctUeir.. nt if comprehended therein;

(Signed)

IL W. DeSausstjre,

Theodore GaierarS^

Thomas 'Waters*
Exhibit 21.1

SUBSIDIARIES OF ACCELRYS, INC.



|                                       |  |                 
|-------------------------------------- |  | ----------------
|Accelrys GmbH                          |  | (Germany)       
|Accelrys Software Incorporated         |  | (Delaware)      
|Accelrys Limited                       |  | (United Kingdom)
|Accelrys SARL                          |  | (France)        
|Accelrys KK                            |  | (Japan)         
|Accelrys Software Solutions Pvt., Ltd. |  | (India)         
|Symyx Technologies, Inc.               |  | (Delaware)      
|Oxford Molecular Limited               |  | (United Kingdom)
|SciTegic, Inc.                         |  | (Delaware)      
|Synopsys Scientific Systems Limited    |  | (United Kingdom)
|Synomics Limited                       |  | (United Kingdom)
|Symyx Solutions, Inc.                  |  | (Delaware)      
|Symyx International                    |  | (Delaware)      
|Symyx Limited                          |  | (United Kingdom)
|Symyx SARL                             |  | (France)        
|Symyx KK                               |  | (Japan)         
|Symyx GmbH                             |  | (Germany)       
|Symyx Europe SA                        |  | (Switzerland)   
|Symyx AG                               |  | (Sweden)
Exhibit 10.1

 

March 13, 2013

 

Richard Brudnick

Vice President, Co-Head Business Development/M&A

Biogen Idec MA Inc.

14 Cambridge Center

Cambridge, MA 02142

 

M Tonesan Naa-Lamle Amissah

Biogen Idec International Holding Ltd.

Appleby (Bermuda) Ltd.

Canon’s Court, 22 Victoria Street

Hamilton HM 12

Bermuda

 

Dear Richard,

 

Isis and Biogen Idec are parties to the Development, Option and License Agreement dated January 3, 2012 (the “SMA Agreement”) and wish to specify the payment schedule for the $18 million Initiation of the CS3 Study Pre-Licensing Milestone Event under the SMA Agreement.

 

As such, Isis and Biogen Idec agree the $18 million payment for the Initiation of the CS3 Study Pre-Licensing Milestone Event under the SMA Agreement is due as follows and payable within 45 days of receipt of invoice following the applicable event:

 

a.              $3.5 million will be due upon the dosing of the first patient in the first cohort of the ISIS 396443-CS3A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of ISIS 396443 Delivered Intrathecally to Patients with Infantile-Onset Spinal Muscular Atrophy) (the “CS3A Study”);

 

b.              $2.0 million will be due upon the dosing of the first patient in the second cohort of the CS3A Study;

 

c.               $1.5 million will be due upon the dosing of the eighth patient in the second cohort of the CS3A Study; and

 

d.              $11 million will be due upon the dosing of the first patient in the Infantile-Onset Spinal Muscular Atrophy Registration Study (CS3B).

 











 

Except as set forth above, any other provisions of the SMA Agreement will remain in full force and effect.  Capitalized terms used but not defined herein will have the meaning ascribed to such terms in the SMA Agreement.

 

This letter agreement may be signed in counterparts, each of which will be deemed an original. Facsimile signatures and signatures transmitted via electronic mail in PDF format will be treated as original signatures.

 

IN WITNESS WHEREOF, Isis and Biogen Idec have caused this letter agreement to be executed by their representatives as of the date hereof.

 

 

	
BIOGEN   IDEC INTERNATIONAL HOLDING LTD
    	
 
    
	
 
    	
 
    
	
/s/   M. Tonesan N. Amissah
    	
 
    
	
M.   Tonesan N. Amissah
    	
 
    
	
 
    	
 
    
	
Director,   Biogen Idec International Holding Ltd.
    	
 
    
	
 
    	
 
    
	
 
    	
 
    
	
ISIS   PHARMACEUTICALS, INC.
    	
 
    
	
 
    	
 
    
	
/s/   B. Lynne Parshall
    	
 
    
	
/s/   B. Lynne Parshall
    	
 
    
	
Chief   Operating Officer
Opinion issued October 30, 2018

In The

Court of Appeals 

For The 

First District of Texas 

————————————

NO. 01-18-00870-CV

———————————

IN RE ANTHONY WELCH, Relator

Original Proceeding on Petition for Writ of Mandamus

MEMORANDUM OPINION

Relator, Anthony Welch, has filed a petition for writ of mandamus, arguing 

that the trial court denied his right to a trial by jury.*

We deny the petition for writ of mandamus. See TEX. R. APP. P. 52.8(a). We 

dismiss any pending motions as moot.

 

* The underlying case is Fulghum Inc. v. Anthony Welch and all Occupants, cause 

number 18-CCV-062505, pending in the County Court at Law No. 4 of Fort Bend

County, Texas, the Honorable Jerry W. Bussell presiding.
2

PER CURIAM

Panel consists of Chief Justice Radack and Justices Brown and Caughey.
<Page>

                                                                    EXHIBIT 23.1

                         CONSENT OF INDEPENDENT AUDITORS

We consent to the incorporation by reference in the Registration Statements on
Form S-3 (Nos. 333-28239, 333-90399, 333-31344, 333-33770, 333-42770, 333-75168,
and 333-82654) and Form S-4 (Nos. 333-33912, 333-42778, and 333-75882) and in
the related Prospectuses and in Form S-8 (Nos. 333-15355, 333-15353, 333-29321,
333-15349, 333-15357, 333-29319, 333-84381, 333-84373, 333-84377, 333-93397,
333-93249, 333-35896, 333-38472, 333-71396, 333-71398, 333-81234, 333-82598 and
333-102543) of Millennium Pharmaceuticals, Inc. of our report dated January 17,
2003, with respect to the consolidated financial statements of Millennium
Pharmaceuticals, Inc. included in this Annual Report (Form 10-K) for the year
ended December 31, 2002.


                                                 /s/ Ernst & Young LLP


Boston, Massachusetts
March 3, 2003
UNITED STATES DISTRICT COURT

FOR THE DISTRICT OF COLUMBIA

___________________________________ )

JOHNNY RAY CHANDLER, SR., )

)

Plaintiff, )

)

v. ) Civil Action No. 06

- 0664 (PLF)

)

UNITED STATES PAROLE )

COMMISSION

, et al

., )

)

Defendants. )

___________________________________ )

ORDER

For the reasons set forth in the accompanying Opinion issued this same day, it is

hereby

ORDERED that the plaintiff’s motion for summary judgment [Dkt. No. 132] is

GRANTED IN PART and DENIED IN PART . The Court denies judgment to the plaintiff on his

Adm inistrative Procedure Act claim, and grants judgment to the plaintiff on his procedural due

process claim ; it is

FURTHER ORDERED that prior to any imposition by defendant United States

Parole Commission of a Special Sex Offender Aftercare Condition upon the plaintiff’s parole , or

any similar condition or conditions including ass ignment to the Sex Offender Unit of the Court

Services and Offender Supervision Agency for the District of Columbia and assignment to sex

offender treatment, the defendants must provide the plaintiff with the following procedural

protections:

(1) written notice that sex offender classification and

conditions are being considered;2 (2) a hearing, held sufficiently after the notice to permit

him to prepare, at which disclosure is made of the evidence being

relied upon for the classification and sex offender conditions ;

(3) an opportunity at the hearing to be heard in person, to

present documentary evidence

, to present testimony of witnesses,

and to confront and cross

- examine witnesses called by the

government, except upon a finding, not arbitr arily made, of good

cause for not permitting such presentation, confrontation, or cross

examination;

(4) administration of the hearing by an independent

decision

- maker;

(5) a written statement by the independent decision

- maker

as to the evidence reli ed on and the reasons for classifying him as a

sex offender and imposing sex offender conditions; and

(6) effective and timely noti ce of all the foregoing rights ;

it is

FURTHER ORDERED that the defendants’ motion for an extension of time

[Dkt. No. 152] to suppleme nt the record is DENIED AS MOOT; and it is

FURTHER ORDERED that the plaintiff’s motion to strike and for sanctions

[Dkt. No. 159] is DENIED AS MOOT.

SO ORDERED.

/s/

_______________________ PAUL L. FRIEDMAN

United States District Judge

DATE: August 8, 2014
Exhibit 32.1




CERTIFICATION PURUSANT TO 18 U.S.C. 1350


AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002





In connection with the Annual Report of PhytoMedical Technologies, Inc. (the “Company”) on Form 10-K for the fiscal year ended December 31, 2010 as filed with the Securities and Exchange Commission on March 28, 2011 (the “Report”), I, Amit S. Dang, President, Chief Executive Officer, and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:





(1)         The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and





(2)         The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.





Date:  March 28, 2011
/s/ Amit S. DangAmit S. DangPresident, Chief Executive Officer,Chief Financial Officer, Director
EXHIBIT 32.1

Certification Pursuant to 18 U.S.C. Section 1350 As Adopted Pursuant to Section
                     906 of the Sarbanes-Oxley Act of 2002


I, L. B. (Brad) Clarke, Chief Executive Officer of Organetix, Inc. (the
"Company"), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
18 U.S.C. Section 1350, that:

(1) the Quarterly Report on Form 10-QSB of the Company for the quarter ended
June 30, 2005 (the "Report") fully complies with the requirements of Section
13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) the information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company.


Date: August 15, 2005

/s/ L. B. (Brad) Clarke
-------------------------------
L. B. (Brad) Clarke
Chief Executive Officer
EXHIBIT 1

CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Graham Newall, certify that:

1. I have reviewed this quarterly report on Form 10-QSB of Paygard, Inc.;

2. Based on my knowledge, this quarterly report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this quarterly
report;

3. Based on my knowledge, the financial statements, and other financial
information included in this quarterly report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this quarterly report;

4. The registrant's other certifying officer and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-14 and 15d-14) for the registrant and have:

a) designed such disclosure controls and procedures to ensure that material
information relating to the registrant, including its consolidated subsidiaries,
is made known to us by others within those entities, particularly during the
period in which this quarterly report is being prepared; b) evaluated the
effectiveness of the registrant's disclosure controls and procedures as of a
date within 90 days prior to the filing date of this quarterly report (the
"Evaluation Date"); and c) presented in this quarterly report our conclusions
about the effectiveness of the disclosure controls and procedures based on our
evaluation as of the Evaluation Date;

5. The registrant's other certifying officer and I have disclosed, based on our
most recent evaluation, to the registrant's auditors and the audit committee of
registrant's board of directors (or persons performing the equivalent
functions):

a) all significant deficiencies in the design or operation of internal controls
which could adversely affect the registrant's ability to record, process,
summarize and report financial data and have identified for the registrant's
auditors any material weaknesses in internal controls; and b) any fraud, whether
or not material, that involves management or other employees who have a
significant role in the registrant's internal controls.


Date: April 19, 2004

                                                     /s/Graham Newall
                                                     -----------------------
                                                     Graham Newall
                                                     Chief Executive Officer
I 

111TH CONGRESS 

1ST SESSION H. R. 4034 

To amend title 10, United States Code, to authorize the Secretary of the 

Army to lease portions of the Airborne and Special Operations Museum 

facility to the Airborne and Special Operations Museum Foundation 

to support operation of the Museum. 

IN THE HOUSE OF REPRESENTATIVES 

NOVEMBER 5, 2009 

Mr. KISSELL (for himself and Mr. ETHERIDGE) introduced the following bill; 

which was referred to the Committee on Armed Services 

A BILL 

To amend title 10, United States Code, to authorize the 

Secretary of the Army to lease portions of the Airborne 

and Special Operations Museum facility to the Airborne 

and Special Operations Museum Foundation to support 

operation of the Museum. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. LEASE OF AIRBORNE AND SPECIAL OPER4 ATIONS MUSEUM FACILITY. 

5 (a) IN GENERAL.—Chapter 449 of title 10, United 

6 States Code, is amended by inserting after section 4772 

7 the following new section: 


tjames on DSKG8SOYB1PROD with BILLS
2 

•HR 4034 IH

1 ‘‘§ 4773. Lease of Airborne and Special Operations 

2 Museum facility 

3 ‘‘(a) AUTHORIZATION OF LEASE.—Under such terms 

4 and conditions as the Secretary of the Army considers ap5 propriate, the Secretary may lease portions of the facility 

6 of the Airborne and Special Operations Museum to the 

7 Airborne and Special Operations Museum Foundation to 

8 be used by the Foundation, consistent with the purpose 

9 of the Museum, for— 

10 ‘‘(1) generating revenue for activities of the 

11 Museum through rental use by the public, commer12 cial and nonprofit entities, State and local govern13 ments, and other Federal agencies; and 

14 ‘‘(2) such administrative purposes as may be 

15 necessary for the support of the Museum. 

16 ‘‘(b) LIMITATION ON ANNUAL CONSIDERATION FOR

17 LEASE.—The annual amount of consideration paid to the 

18 Secretary of the Army by the Airborne and Special Oper19 ations Museum Foundation for a lease under subsection 

20 (a) may not exceed an amount equal to the actual cost, 

21 as determined by the Secretary, of the annual operations 

22 and maintenance of the Airborne and Special Operations 

23 Museum. 

24 ‘‘(c) USE OF PROCEEDS OF LEASE.—Notwith25 standing any other provision of law, the Secretary of the 

26 Army shall use amounts paid under subsection (b) to cover 


tjames on DSKG8SOYB1PROD with BILLS
3 

•HR 4034 IH

1 the costs of operation of the Airborne and Special Oper2 ations Museum.’’. 

3 (b) CLERICAL AMENDMENT.—The table of sections 

4 at the beginning of such chapter is amended by inserting 

5 after the item relating to section 4772 the following new 

6 item: 

‘‘4773. Lease of Airborne and Special Operations Museum facility.’’. 

Æ 


tjames on DSKG8SOYB1PROD with BILLS
----

| (1)     | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|------------------------|----------------------------------------------------------------------------------------------------------------------------|

| (2)     | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------|

| Dated:  August 22, 2011 | By:    | /s/  Kyle Kennedy                                                                                                           |   |
|-----------------------------------|--------|----------------------------------------------------------------------------------------------------------------------------------|--------|
|                              |   | Kyle Kennedy                                                                                                                     |   |
|                              |   | President,Chief Executive Officer and Chairman of the Board(Principal Executive Officer and acting Principal Accounting Officer) |   |